Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Peters

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Current Topics in Medicinal Chemistry|December 27, 2005
Inhibitors of dipeptidyl peptidase IV--recent advances and structural viewsDaniel Hunziker, Michael Hennig, Jens-Uwe Peters
Plos One|July 5, 2024
Hasty generalizations and generics in medical research: A systematic reviewUwe Peters, Henrik Røed Sherling, Benjamin Chin-Yee
Chemmedchem|March 7, 2009
Pharmacological promiscuity: dependence on compound properties and target specificity in a set of recent Roche compoundsJens-Uwe Peters, Patrick Schnider, Patrizio Mattei, et al.
Chemical Communications (Cambridge, England)|April 22, 2003
Iminium ion catalysis: use of the alpha-effect in the acceleration of the Diels-Alder reactionJulie L Cavill, Jens-Uwe Peters, Nicholas C O Tomkinson
Bioorganic & Medicinal Chemistry Letters|November 14, 2007
Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidationJens-Uwe Peters, Thomas Lübbers, Alexander Alanine, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetrationJens-Uwe Peters, Thomas Lübbers, Alexander Alanine, et al.
Chimia|December 4, 2023
Details Matter in Structure-based Drug DesignBernd Kuhn, Jens-Uwe Peters, Markus G Rudolph, et al.
Public Understanding of Science (Bristol, England)|April 20, 2026
Generics in science communication: Misaligned interpretations across laypeople, scientists, and large language modelsUwe Peters, Andrea Bertazzoli, Jasmine M DeJesus, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2007
Novel orally active, dibenzazepinone-based gamma-secretase inhibitorsJens-Uwe Peters, Guido Galley, Helmut Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Aminomethylpyridines as DPP-IV inhibitorsJens-Uwe Peters, Silja Weber, Stéphane Kritter, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Current Topics in Medicinal Chemistry|December 27, 2005
Inhibitors of dipeptidyl peptidase IV--recent advances and structural viewsDaniel Hunziker, Michael Hennig, Jens-Uwe Peters
Plos One|July 5, 2024
Hasty generalizations and generics in medical research: A systematic reviewUwe Peters, Henrik Røed Sherling, Benjamin Chin-Yee
Chemmedchem|March 7, 2009
Pharmacological promiscuity: dependence on compound properties and target specificity in a set of recent Roche compoundsJens-Uwe Peters, Patrick Schnider, Patrizio Mattei, et al.
Chemical Communications (Cambridge, England)|April 22, 2003
Iminium ion catalysis: use of the alpha-effect in the acceleration of the Diels-Alder reactionJulie L Cavill, Jens-Uwe Peters, Nicholas C O Tomkinson
Bioorganic & Medicinal Chemistry Letters|November 14, 2007
Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidationJens-Uwe Peters, Thomas Lübbers, Alexander Alanine, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetrationJens-Uwe Peters, Thomas Lübbers, Alexander Alanine, et al.
Chimia|December 4, 2023
Details Matter in Structure-based Drug DesignBernd Kuhn, Jens-Uwe Peters, Markus G Rudolph, et al.
Public Understanding of Science (Bristol, England)|April 20, 2026
Generics in science communication: Misaligned interpretations across laypeople, scientists, and large language modelsUwe Peters, Andrea Bertazzoli, Jasmine M DeJesus, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2007
Novel orally active, dibenzazepinone-based gamma-secretase inhibitorsJens-Uwe Peters, Guido Galley, Helmut Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Aminomethylpyridines as DPP-IV inhibitorsJens-Uwe Peters, Silja Weber, Stéphane Kritter, et al.
Pageof 5